News
Pharmaceutical Technology on MSN15h
Alfasigma sets stage for Jyseleca in axSpA after Phase III win
Alfasigma is in discussions with the EMA and MHRA about Jyseleca for axSpA but has yet to reveal any plans for US submission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback